MNKD - MannKind Corporation Stock Price and Quote

MNKD [NASD]

Index	-	P/E	-	EPS (ttm)	-0.39	Insider Own	2.20%	Shs Outstand	259.30M	Perf Week	1.84%
Market Cap	1.39B	Forward P/E	-	EPS next Y	-0.16	Insider Trans	-0.20%	Shs Float	246.92M	Perf Month	6.17%
Income	-97.50M	PEG	-	EPS next Q	-0.06	Inst Own	50.30%	Short Float / Ratio	13.29% / 7.52	Perf Quarter	52.47%
Sales	76.20M	P/S	18.27	EPS this Y	-26.30%	Inst Trans	8.33%	Short Interest	32.81M	Perf Half Y	21.13%
Book/sh	-0.92	P/B	-	EPS next Y	50.00%	ROA	-32.30%	Target Price	6.10	Perf Year	48.16%
Cash/sh	0.61	P/C	8.44	EPS next 5Y	35.60%	ROE	42.10%	52W Range	2.49 - 5.51	Perf YTD	-0.47%
Dividend	-	P/FCF	-	EPS past 5Y	-17.50%	ROI	-37.30%	52W High	-4.81%	Beta	1.69
Dividend %	-	Quick Ratio	3.40	Sales past 5Y	-15.50%	Gross Margin	30.70%	52W Low	110.64%	ATR	0.24
Employees	348	Current Ratio	3.70	Sales Q/Q	47.70%	Oper. Margin	-98.80%	RSI (14)	56.14	Volatility	4.96% 5.09%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-214.30%	Profit Margin	-	Rel Volume	0.51	Prev Close	5.18
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 08 BMO	Payout	-	Avg Volume	4.36M	Price	5.24
Recom	1.70	SMA20	5.08%	SMA50	6.65%	SMA200	31.62%	Volume	658,037	Change	1.25%

May-14-21

Initiated

RBC Capital Mkts

Sector Perform

Dec-24-19

Initiated

Oppenheimer

Outperform

$2.50

Oct-25-19

Initiated

Cantor Fitzgerald

Overweight

May-14-19

Initiated

BTIG Research

Buy

Mar-04-19

Initiated

SVB Leerink

Outperform

Feb-22-19

Initiated

SVB Leerink

Outperform

Feb-28-18

Downgrade

Maxim Group

Hold → Sell

Nov-01-17

Downgrade

Maxim Group

Buy → Hold

Oct-10-17

Initiated

H.C. Wainwright

Buy

Oct-06-17

Reiterated

Maxim Group

Buy

$4 → $7

Show Previous Ratings

Jan-24-23 06:00AM	MannKind Corporation to Participate in the Lytham Partners Investor Select Conference GlobeNewswire +6.79%
Jan-23-23 06:05AM	MannKinds Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease GlobeNewswire
Jan-18-23 08:00AM	3 Biotech Stocks Under $15 Worth a Second Look in 2023 Motley Fool
Jan-17-23 06:36AM	MannKind's (NASDAQ:MNKD) investors will be pleased with their impressive 183% return over the last three years Simply Wall St. -5.38%
Jan-05-23 06:00AM	MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference GlobeNewswire
07:11AM	Loading…
Dec-31-22 07:11AM	Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 44% Undervaluation? Simply Wall St.
Dec-06-22 09:55AM	After Golden Cross, MannKind (MNKD)'s Technical Outlook is Bright Zacks
Nov-30-22 12:29PM	MannKind Corporation (NASDAQ:MNKD) is a favorite amongst institutional investors who own 52% Simply Wall St. +5.64%
Nov-10-22 06:05AM	MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting GlobeNewswire +10.10%
05:31AM	MannKind Third Quarter 2022 Earnings: Beats Expectations Simply Wall St.
Nov-08-22 04:30PM	MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript Motley Fool
09:15AM	MannKind (MNKD) Reports Q3 Loss, Tops Revenue Estimates Zacks
08:00AM	MannKind Corporation Reports 2022 Third Quarter Financial Results GlobeNewswire
Nov-01-22 06:00AM	MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022 GlobeNewswire
Sep-29-22 11:38AM	7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up InvestorPlace -5.97%
06:13AM	Loading…
06:13AM	When Can We Expect A Profit From MannKind Corporation (NASDAQ:MNKD)? Simply Wall St.
Sep-21-22 05:00PM	MannKind Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference GlobeNewswire
Sep-19-22 06:00AM	7 Penny Stocks That Actually Have a Buy Rating InvestorPlace
Sep-08-22 01:18PM	A number of insiders bought MannKind Corporation (NASDAQ:MNKD) stock last year, which is great news for shareholders Simply Wall St. +5.32%
Sep-06-22 06:15AM	Mannkind Successfully Completes Phase 1 Study of Inhaled Clofazimine GlobeNewswire -5.29%
Sep-01-22 06:00AM	MannKind Corporation to Participate in the H.C. Wainwright 24th Annual Global Investment Conference GlobeNewswire +9.04%
Aug-25-22 09:09AM	10 Stocks That Jumped After Jim Cramers Negative Call Insider Monkey
Aug-19-22 06:18AM	Analysts Are Betting On MannKind Corporation (NASDAQ:MNKD) With A Big Upgrade This Week Simply Wall St.
Aug-16-22 09:03AM	Jim Cramer Recommends Selling These 10 Stocks in August Insider Monkey
Aug-10-22 07:19AM	MannKind's (NASDAQ:MNKD) investors will be pleased with their stellar 268% return over the last three years Simply Wall St.
05:30AM	MannKind Corporation (MNKD) Q2 2022 Earnings Call Transcript Motley Fool
Aug-09-22 05:15PM	MannKind (MNKD) Reports Q2 Loss, Tops Revenue Estimates Zacks -5.98%
05:00PM	Edited Transcript of MNKD.OQ earnings conference call or presentation 9-Aug-22 9:00pm GMT Thomson Reuters StreetEvents
04:00PM	MannKind Corporation Reports 2022 Second Quarter Financial Results GlobeNewswire
Aug-02-22 06:00AM	MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022 GlobeNewswire +10.06%
07:35PM	Loading…
Aug-01-22 07:35PM	Why Shares of MannKind Corporation Climbed 10.4% on Monday Motley Fool
06:00AM	MannKind Corporation to Participate in the BTIG Biotechnology Conference GlobeNewswire
Jul-26-22 10:13AM	What's in Store for United Therapeutics' (UTHR) Q2 Earnings? Zacks
Jun-20-22 09:28AM	Allogene Therapeutics (ALLO) Moves 16.4% Higher: Will This Strength Last? Zacks
07:22AM	What Is The Ownership Structure Like For MannKind Corporation (NASDAQ:MNKD)? Simply Wall St.
Jun-03-22 10:00AM	Mannkind to Host Product Theater and Booth at the American Diabetes Associations 82nd Scientific Sessions in New Orleans, June 3-7 GlobeNewswire +11.35%
May-25-22 10:16AM	United Therapeutics (UTHR) Gains on Tyvaso DPI Approval Zacks
May-24-22 06:00AM	MannKinds Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI GlobeNewswire
May-19-22 06:00AM	MannKind Corporation to Ring the Nasdaq Stock Market Opening Bell GlobeNewswire +10.03%
May-17-22 06:06AM	MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand Pharma GlobeNewswire +9.80%
May-09-22 06:00AM	MannKind Corporation Participating at Upcoming Conferences GlobeNewswire -6.10%
May-06-22 01:30AM	MannKind Corporation (MNKD) Q1 2022 Earnings Call Transcript Motley Fool
May-05-22 05:25PM	MannKind (MNKD) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:00PM	MannKind Corporation Reports 2022 First Quarter Financial Results GlobeNewswire
May-04-22 06:15PM	Regenxbio (RGNX) Reports Q1 Loss, Misses Revenue Estimates Zacks
Apr-28-22 06:00AM	MannKind Corporation to Hold 2022 First Quarter Financial Results Conference Call on May 5, 2022 GlobeNewswire
Apr-27-22 10:35AM	Solid Biosciences Inc. (SLDB) Reports Q1 Loss, Misses Revenue Estimates Zacks
06:05AM	MannKind Presents Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30 GlobeNewswire
Apr-21-22 10:38AM	Loss-Making MannKind Corporation (NASDAQ:MNKD) Expected To Breakeven In The Medium-Term Simply Wall St.
Mar-28-22 06:05AM	MannKind Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference GlobeNewswire
Mar-22-22 06:05AM	MannKind Corporation to Participate in the Cantor Virtual Rare Orphan Disease Summit GlobeNewswire +5.20%
Mar-08-22 06:05AM	MannKind Corporation to Participate in Oppenheimer 32nd Annual Healthcare Conference GlobeNewswire
Mar-07-22 05:59AM	Trade Alert: The Independent Director Of MannKind Corporation (NASDAQ:MNKD), Jennifer Grancio, Has Just Spent US$300k Buying 83% More Shares Simply Wall St.
Mar-03-22 05:25AM	Recent 11% pullback isn't enough to hurt long-term MannKind (NASDAQ:MNKD) shareholders, they're still up 85% over 3 years Simply Wall St.
Feb-25-22 12:30AM	MannKind Corporation (MNKD) Q4 2021 Earnings Call Transcript Motley Fool -6.53%
Feb-24-22 04:00PM	MannKind Corporation Reports 2021 Fourth Quarter and Full Year Financial Results GlobeNewswire -20.49%
06:05AM	Update on Tyvaso DPI New Drug Application GlobeNewswire
Feb-21-22 09:05AM	MannKind Corporation to Hold 2021 Fourth Quarter and Full Year Financial Results Conference Call on February 24, 2022 GlobeNewswire
Feb-10-22 06:05AM	MannKind Corporation to Participate in SVB Leerink 2022 Global Healthcare Conference GlobeNewswire
Jan-24-22 05:38PM	Pacific Wealth Strategies Group, Inc. Buys Ulta Beauty Inc, UnitedHealth Group Inc, KLA Corp, ... GuruFocus.com
Jan-11-22 07:14AM	How Much Of MannKind Corporation (NASDAQ:MNKD) Do Institutions Own? Simply Wall St.
Jan-05-22 06:10AM	MannKind Corporation to Participate in H.C. Wainwright Bioconnect Conference GlobeNewswire
06:05AM	MannKind Extends Collaboration With Thirona Bio on Fibrotic Lung Diseases GlobeNewswire
Dec-06-21 06:05AM	MannKind Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference GlobeNewswire
Nov-09-21 07:55PM	MannKind (MNKD) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM	MannKind Corporation Reports 2021 Third Quarter Financial Results GlobeNewswire
06:05AM	Mannkind Corporation Closes Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds GlobeNewswire
Nov-05-21 07:05AM	MannKind Presents Data at 21st Annual Diabetes Technology Meeting GlobeNewswire
Nov-02-21 06:05AM	MannKind Corporation to Hold 2021 Third Quarter Financial Results Conference Call on November 9, 2021 GlobeNewswire
Oct-27-21 03:03PM	Will MannKind (MNKD) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-20-21 01:28AM	United Therapeutics' (UTHR) Tyvaso DPI NDA Gets CRL From FDA (Revised) Zacks
Oct-19-21 10:29AM	United Therapeutics' (UTHR) Tyvaso DPI NDA Gets CRL From FDA Zacks
Oct-18-21 02:38PM	United Therapeutics hits speed bump in its quest for new drug approval American City Business Journals -18.27%
02:37PM	Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher Benzinga
12:37PM	Why Shares of MannKind Corporation Are Falling This Morning Motley Fool
11:42AM	MannKind's stock falls 18% after FDA says it will not approve application for hypertension drug MarketWatch
09:20AM	Why MannKind Shares Are Falling Today Benzinga
08:45AM	FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease Benzinga
06:36AM	UPDATE 1-U.S. FDA declines to approve United-Mannkind's lung disease therapy Reuters
06:02AM	United Therapeutics, Mannkind Fall After FDA Declines to Approve Lung Drug Investing.com
06:00AM	Progress Update on Tyvaso DPI New Drug Application GlobeNewswire
Oct-04-21 08:11AM	Do Options Traders Know Something About MannKind (MNKD) Stock We Don't? Zacks
07:05AM	MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population PR Newswire
07:05AM	MannKind Announces First Patient Enrolled in INHALE-1 Study of Afrezza® in Pediatric Population GlobeNewswire
Sep-30-21 07:43AM	The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga
Sep-29-21 04:24PM	Mannkind Corporation Announces Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds GlobeNewswire
Sep-28-21 10:05AM	As MannKind Corporation (NASDAQ:MNKD) gains 7.1%, insiders who bought last year may be wishing they had bet higher Simply Wall St.
06:05AM	MannKind Corporation to Participate at Lytham Partners Fall 2021 Investor Conference GlobeNewswire
Sep-15-21 06:05AM	Mannkind Corporation Participating at Upcoming Conferences GlobeNewswire
Sep-07-21 09:54AM	United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients Benzinga
06:05AM	MannKind Corporation to Participate in H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire
06:00AM	United Therapeutics Presents Tyvaso DPI BREEZE Clinical Data At The European Respiratory Society International Congress 2021 PR Newswire
Aug-14-21 03:40AM	US$6.17: That's What Analysts Think MannKind Corporation (NASDAQ:MNKD) Is Worth After Its Latest Results Simply Wall St.
Aug-12-21 11:30AM	MannKind Corporation (MNKD) Q2 2021 Earnings Call Transcript Motley Fool
Aug-11-21 05:15PM	MannKind (MNKD) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:00PM	MannKind Corporation Reports 2021 Second Quarter Financial Results GlobeNewswire
Aug-04-21 06:48AM	NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI (aviptadil) Inhaler for Respiratory Conditions PR Newswire
06:48AM	MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI (aviptadil) Based On The Technosphere® Platform PR Newswire
06:15AM	MannKind Corporation to Hold 2021 Second Quarter Financial Results Conference Call on August 11, 2021 GlobeNewswire
Aug-03-21 09:00AM	MannKind Corporation to Participate in the BTIG Virtual Biotechnology Conference 2021 GlobeNewswire

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thomson David	EVP Genl Counsel & Secretary	Aug 29	Sale	3.67	7,000	25,690	726,035	Aug 29 09:00 PM
Galindo Alejandro	EVP Endocrine Business Unit	Aug 22	Sale	3.85	4,615	17,771	777,075	Aug 23 09:00 PM
Galindo Alejandro	EVP Endocrine Business Unit	Jul 31	Buy	2.93	5,000	14,650	781,690	Aug 01 06:00 AM
Tross Stuart A	Chief People & Workpl Officer	Jul 31	Buy	2.93	4,581	13,422	830,650	Aug 01 06:00 AM
Binder Steven B.	Chief Financial Officer	Jul 31	Buy	2.93	791	2,318	728,997	Aug 01 06:00 AM
Castagna Michael	Chief Executive Officer	Jul 31	Buy	2.93	3,147	9,221	2,084,486	Aug 01 06:00 AM
MUNDKUR CHRISTINE	Director	Feb 28	Buy	2.71	27,675	74,999	254,493	Mar 01 05:00 PM
HOOPER ANTHONY C	Director	Feb 28	Buy	2.71	40,000	108,400	338,394	Mar 01 05:00 PM
Galindo Alejandro	Chief Commercial Officer	Feb 28	Buy	2.71	36,900	99,999	576,690	Mar 01 05:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience